Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioresonance of Bivalve Fluids in COVID-19
NCT05054075Phase 2Unknown
- Sponsor
- University of Porto
- Start
- Oct 2021
- Primary completion
- Oct 2022
- Countries
- 1
01
Overview
Phase 2, open-label trial in coronavirus disease 2019 (COVID-19) and severe acute respiratory syndrome (SARS) (3 arms), sponsored by University of Porto. Primary endpoints: Pulmonary system parameters at Day 3, Cardiac system parameters at Day 3 and 1 more. Status: unknown.
02
Conditions
coronavirus disease 2019 (COVID-19)severe acute respiratory syndrome (SARS)
Beyond the preview
Go deeper on NCT05054075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05054075.